Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.43 |
| ▸ | LPAR2 | Q9HBW0 | 5/20 | 0.43 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.43 |
| ▸ | NAAA | Q02083 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | GBA1 | P04062 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15092019 | 1.00 | — | — | |
| SCHEMBL21581249 | 1.00 | THRB (0.44) | THRBMEN1KMT2AHTTMAPT | |
| SCHEMBL17937906 | 1.00 | THRB (0.44) | THRBMEN1KMT2AHTTMAPT | |
| SCHEMBL21581268 | 1.00 | THRB (0.44) | THRBMEN1KMT2AHTTMAPT | |
| SCHEMBL21581256 | 1.00 | THRB (0.44) | THRBMEN1KMT2AHTTMAPT | |
| SCHEMBL45784 | 0.97 | — | — | |
| Alcohol SCHEMBL28159426 | 0.84 | TSHR (0.44) | THRBMEN1KMT2AHTTMAPT | |
| Acetonitrile SCHEMBL28980702 | 0.78 | TSHR (0.34) | TSHRALDH1A1 | |
| SCHEMBL21581247 | 0.78 | THRB (0.47) | THRBMEN1KMT2AHTTMAPT | |
| SCHEMBL14688826 | 0.78 | THRB (0.47) | THRBMEN1KMT2AHTTMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3575289-B1 | ALKANOLAMINE, FRICTION-REDUCING AGENT, AND LUBRICATING OIL COMPOSITION | TOSOH CORP (JP) | 2023-04-19 | — | — | EP | disclosed |
| US-10927084-B2 | Alkanolamine, friction-reducing agent, and lubricating oil composition | TOSOH CORPORATION (JP) | 2021-02-23 | — | — | US | disclosed |
| EP-3048107-B1 | BENZOBIS (THIADIAZOLE) DERIVATIVE, INK CONTAINING SAME, AND ORGANIC ELECTRONIC DEVICE USING SAME | FUTURE INK CORP (JP) | 2021-01-13 | — | — | EP | disclosed |
| US-20200039942-A1 | ALKANOLAMINE, FRICTION-REDUCING AGENT, AND LUBRICATING OIL COMPOSITION | TOSOH CORPORATION (JP) | 2020-02-06 | — | — | US | disclosed |
| EP-3575289-A1 | ALKANOLAMINE, FRICTION-REDUCING AGENT, AND LUBRICATING OIL COMPOSITION | Tosoh Corporation (JP) | 2019-12-04 | — | — | EP | disclosed |
| US-9978954-B2 | Benzobis (thiadiazole) derivative, ink comprising same, and organic electronic device comprising same | UBE INDUSTRIES, LTD. (JP) | 2018-05-22 | — | — | US | disclosed |
| US-20160276598-A1 | BENZOBIS (THIADIAZOLE) DERIVATIVE, INK COMPRISING SAME, AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME | FUTURE INK CORPORATION (JP) | 2016-09-22 | — | — | US | disclosed |
| EP-3048107-A1 | BENZOBIS (THIADIAZOLE) DERIVATIVE, INK CONTAINING SAME, AND ORGANIC ELECTRONIC DEVICE USING SAME | UBE Industries, Ltd. (JP) | 2016-07-27 | — | — | EP | disclosed |
| US-7964649-B2 | Hydrindane analogs having sphingosine 1-phosphate receptor agonist activity | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2011-06-21 | — | — | US | disclosed |
| US-7915315-B2 | Benzocycloheptyl analogs having sphingosine 1-phosphate receptor activity | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2011-03-29 | — | — | US | disclosed |
| US-7786173-B2 | Tetralin analogs having sphingosine 1-phosphate agonist activity | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2010-08-31 | — | — | US | disclosed |
| US-20090253760-A1 | HYDRINDANE ANALOGS HAVING SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST ACTIVITY | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2009-10-08 | — | — | US | disclosed |
| US-20090253761-A1 | BENZOCYCLOHEPTYL ANALOGS HAVING SPHINGOSINE 1-PHOSPHATE RECEPTOR ACTIVITY | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2009-10-08 | — | — | US | disclosed |
| US-20090253759-A1 | TETRALIN ANALOGS HAVING SPHINGOSINE 1-PHOSPHATE AGONIST ACTIVITY | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2009-10-08 | — | — | US | disclosed |
| EP-2099741-A2 | HYDRINDANE ANALOGS HAVING SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST ACTIVITY | University Of Virginia Patent Foundation (US) | 2009-09-16 | — | — | EP | disclosed |
| EP-2097397-A1 | TETRALIN ANALOGS HAVING SPHINGOSINE 1-PHOSPHATE AGONIST ACTIVITY | University Of Virginia Patent Foundation (US) | 2009-09-09 | — | — | EP | disclosed |
| EP-2097371-A2 | BENZOCYCLOHEPTYL ANALOGS HAVING SPHINGOSINE 1-PHOSPHATE RECEPTOR ACTIVITY | University Of Virginia Patent Foundation (US) | 2009-09-09 | — | — | EP | disclosed |
| WO-2008064320-A2 | HYDRINDANE ANALOGS HAVING SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST ACTIVITY | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2008-05-29 | — | — | WO | disclosed |
| WO-2008064337-A2 | BENZOCYCLOHEPTYL ANALOGS HAVING SPHINGOSINE 1-PHOSPHATE RECEPTOR ACTIVITY | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2008-05-29 | — | — | WO | disclosed |
| WO-2008064315-A1 | TETRALIN ANALOGS HAVING SPHINGOSINE 1-PHOSPHATE AGONIST ACTIVITY | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2008-05-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160276598-A1 | BENZOBIS (THIADIAZOLE) DERIVATIVE, INK COMPRISING SAME, AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME | BRD3, TH, BRS3 | THRB 1495/4885MEN1 1323/4885KMT2A 2120/4885 |
| US-20090253760-A1 | HYDRINDANE ANALOGS HAVING SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST ACTIVITY | S1PR1, S1PR3, S1PR2 | THRB 215/4885MEN1 2536/4885KMT2A 2642/4885 |
| US-20200039942-A1 | ALKANOLAMINE, FRICTION-REDUCING AGENT, AND LUBRICATING OIL COMPOSITION | APOB, HRH3, PHOSPHO1 | THRB 1854/4885MEN1 3143/4885KMT2A 1714/4885 |
| US-10927084-B2 | Alkanolamine, friction-reducing agent, and lubricating oil composition | APOB, HRH3, PHOSPHO1 | THRB 1854/4885MEN1 3143/4885KMT2A 1714/4885 |
| US-20090253759-A1 | TETRALIN ANALOGS HAVING SPHINGOSINE 1-PHOSPHATE AGONIST ACTIVITY | S1PR1, S1PR4, S1PR2 | THRB 29/4885MEN1 1426/4885KMT2A 3921/4885 |
| US-20090253761-A1 | BENZOCYCLOHEPTYL ANALOGS HAVING SPHINGOSINE 1-PHOSPHATE RECEPTOR ACTIVITY | S1PR1, S1PR4, S1PR2 | THRB 203/4885MEN1 2548/4885KMT2A 3879/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.